Batch tested by Janoshik Analytical. Verify any report with its key on Janoshik's site. See the certificates →

Order before 11am Central for same-day dispatch

TB-500 · 7 cited studies43 vs 3Residues: full-length thymosin beta-4 vs GHK-Cu (copper tripeptide)

TB-500 vs GHK-Cu: How Do They Differ?

Published · Ouralus research desk

Two peptides differ substantially in size and composition: TB-500 is a 43-amino-acid fragment of thymosin beta-4, while GHK-Cu is a 3-residue copper-coordination complex. TB-500 is studied in cultured cells for actin-dynamics signaling and actin-sequestering activity, while GHK-Cu is characterized in fibroblasts for copper-peptide signaling on extracellular-matrix biology. Both are examined as in-vitro research tools for distinct molecular-signaling pathways.

Sequence, structure, and molecular origin

TB-500 is a 43-amino-acid peptide fragment derived from thymosin beta-4, a natural protein found in mammals. The sequence is the complete thymosin beta-4 sequence: MSKGDPPVSSYYIDSLLVGREWSPDHEHDISDDDPFAAFQQSKKSK-COOH. This full-length sequence is sufficiently long to form secondary structures including alpha-helical regions, localized turns, and loops. The 43-residue peptide engages multiple protein-binding partners and exhibits intrinsic disorder in its free state, undergoing conformational changes upon binding to molecular targets.Review · PMID 27450730Review · PMID 17947587

GHK-Cu is a 3-amino-acid tripeptide (Gly-His-Lys) complexed with copper in a 1:1 stoichiometry. The histidine residue coordinates the copper atom, making copper an integral structural component essential to the complex. GHK-Cu is much shorter and contains a metal cofactor essential to its molecular structure and signaling. The tripeptide is synthesized de novo or derived from collagen hydrolysates; it is not a product of a specific natural protein but a minimal peptide selected for copper-binding properties.In vitro · PMID 32371360In vitro · PMID 33263328

The compositional difference between TB-500 and GHK-Cu is fundamental and shapes their molecular properties and research applications. TB-500's 43-residue sequence provides a scaffold for multiple molecular interactions and actin binding, enabling broad molecular interactions with cellular targets. GHK-Cu's minimal 3-residue structure with metal coordination specializes the complex for specific extracellular-matrix signaling interactions dependent on copper coordination. These distinct molecular architectures result in different experimental approaches and biological contexts studied in cultured-cell research systems.Review · PMID 27450730In vitro · PMID 32371360

Actin-binding and dynamics versus extracellular-matrix signaling

TB-500 research is primarily focused on actin-monomer sequestration and actin-dynamics signaling in cultured cell systems. The 43-residue peptide binds G-actin (monomeric actin) with defined stoichiometry, preventing actin polymerization and modulating the cytoskeletal dynamics of cultured cells. TB-500 is characterized as an actin-sequestering protein that participates in cellular mobility, cytoskeletal remodeling, and actin-dependent signaling. Experiments measure actin polymerization state by biochemical assays, cytoskeletal organization by immunofluorescence, and actin-binding kinetics by biophysical methods.In vitro · PMID 1999398In vitro · PMID 10848969

GHK-Cu research is heavily concentrated on extracellular-matrix biology and remodeling responses in cultured fibroblasts. The copper tripeptide is characterized as modulating collagen synthesis, matrix-metalloproteinase expression, and extracellular-matrix-remodeling signaling. Experiments measure collagen-I and collagen-III production by ELISA and Western blotting, matrix-metalloproteinase activity by zymography, and fibroblast-proliferation assays. The copper-peptide complex modulates extracellular-matrix-focused cellular responses.In vitro · PMID 32371360In vitro · PMID 28805225

This mechanistic divergence reflects distinct molecular targets and research contexts. TB-500 targets actin monomers and cytoskeletal dynamics—intracellular molecular systems governing cell mobility and morphology. GHK-Cu targets extracellular-matrix signaling pathways—primarily concerned with matrix-protein synthesis and remodeling signaling. One peptide modulates cytoskeletal dynamics through actin binding; the other modulates extracellular-matrix remodeling through copper-coordinated signaling interactions.In vitro · PMID 1999398In vitro · PMID 32371360

Structural characterization and biophysical studies

TB-500's structural properties have been characterized through nuclear magnetic resonance spectroscopy and biophysical techniques. The 43-residue peptide exhibits conformational disorder in its free state, with NMR spectroscopy revealing localized alpha-helical structural elements within an otherwise disordered sequence. Upon binding to actin monomers, the peptide undergoes a disorder-to-order transition, establishing defined interactions with the actin target. The structural flexibility of TB-500 permits binding to multiple actin molecules and engagement with diverse actin-binding partners.Review · PMID 27450730In vitro · PMID 10848969

GHK-Cu's structural properties are characterized through computational and theoretical studies including density functional theory and molecular dynamics simulation. The copper-peptide complex exhibits defined coordination geometry with stable equatorial and apical bonding environments. Electrochemical studies establish reduction potentials and electron-transfer reversibility at the copper center. The metal-peptide structure remains stable across physiological conditions modeled in in-vitro systems, in contrast to TB-500's conformational flexibility.In vitro · PMID 32371360In vitro · PMID 33263328

The contrast in structural characterization methods reflects the peptides' distinct properties: TB-500 exhibits disorder-to-order transition behavior requiring dynamic NMR and biophysical characterization, while GHK-Cu exhibits stable metal coordination requiring computational and electrochemical analysis. TB-500's intrinsic disorder enables multiple molecular interactions, while GHK-Cu's copper coordination constrains the complex to defined signaling interactions.Review · PMID 27450730In vitro · PMID 32371360

Cultured cell systems and experimental models

TB-500 is characterized in cultured cell types relevant to actin-dependent processes: fibroblasts measuring cell migration and cytoskeletal organization, endothelial cells measuring vascular tube formation and cell mobility, contractile-cell types measuring contractility signaling and actin dynamics, and neural cells measuring neurite outgrowth and axonal dynamics. TB-500 readouts include actin-polymerization assays, cytoskeletal reorganization by immunofluorescence, cell-migration assays, and actin-binding kinetics measured by surface-plasmon resonance or other biophysical techniques.Review · PMID 27450730Review · PMID 17947587

GHK-Cu is characterized primarily in cultured fibroblasts and connective-tissue cells. The copper tripeptide is added to cultured cells, and extracellular-matrix-related molecular readouts are measured: collagen synthesis by ELISA and quantitative reverse-transcription polymerase chain reaction, matrix-metalloproteinase expression by Western blotting and zymography, and fibroblast-proliferation assays. Signaling readouts include phosphorylation of kinases implicated in fibroblast activation.In vitro · PMID 32371360In vitro · PMID 28805225

The cultured cell systems reflect each peptide's primary molecular target and research emphasis. TB-500 is studied in actin-dependent cell types measuring actin dynamics and cell mobility. GHK-Cu is studied in extracellular-matrix-producing cells measuring matrix-remodeling signaling. These distinct experimental models highlight the peptides' specialized roles in different molecular and cellular contexts.Review · PMID 27450730In vitro · PMID 32371360

Absence of comparative studies and research gaps

There is no literature directly comparing TB-500 and GHK-Cu in the same cultured cell systems or assessing their relative potencies for any shared cellular response. The two peptides have not been tested in parallel cultured-cell assays or co-incubated in the same experimental models. The distinct research literatures are conducted independently without cross-comparison studies. The molecular targets and signaling intermediates through which the peptides function have not been directly compared.Review · PMID 27450730In vitro · PMID 32371360

Neither literature has investigated potential interactions between TB-500 and GHK-Cu in cultured cell systems or examined whether the peptides might modulate each other's cellular activity. The role of actin-sequestering activity in modulating extracellular-matrix signaling is not systematically studied. Furthermore, the relative timing and kinetics of TB-500 and GHK-Cu signaling responses, and whether the peptides might coordinate or antagonize cellular responses, remain uncharacterized in the published research.Review · PMID 27450730In vitro · PMID 32371360In vitro · PMID 28805225

The studies at a glance

Representative in-vitro characterization of TB-500 and GHK-Cu in cultured cell systems.

StudyStudy typenWeeksResult
TB-500 actin-sequestering activity—biochemical assayIn vitron/an/aTB-500 bound G-actin monomers stoichiometrically and prevented actin polymerization measured by sedimentation and biochemical assays
TB-500 structural characterization—NMR spectroscopyIn vitron/an/aTB-500 conformation analyzed by NMR spectroscopy; localized alpha-helical structure identified with disorder-to-order transition upon actin binding
TB-500 actin-binding structure-activity relationshipsIn vitron/an/aTB-500 mutants assayed by NMR and actin-binding kinetics; structural requirements for actin binding identified through structure-activity correlation
GHK-Cu copper coordination—theoretical modelingIn vitron/an/aCopper(II) binding to GHK tripeptide modeled by density functional theory and molecular dynamics; coordination geometry calculated and validated
GHK-Cu extracellular-matrix signaling in fibroblastsIn vitron/an/aCopper tripeptide measured for modulation of collagen synthesis and matrix-metalloproteinase expression in cultured fibroblasts via Western blotting and zymography
GHK-Cu structural application in protein crystallographyIn vitron/an/aGHK-Cu tag promoted crystal formation and enabled protein structure determination by copper anomalous-diffraction-based phasing

Frequently asked questions

What is TB-500?

TB-500 is a 43-amino-acid peptide fragment of thymosin beta-4, a natural protein found in mammals. The complete 43-residue sequence is the full-length thymosin beta-4. TB-500 is characterized as an actin-sequestering peptide that binds G-actin monomers and modulates actin-dynamics signaling. It is studied in cultured cell systems for cytoskeletal regulation and cell-mobility signaling through actin binding.Review · PMID 27450730In vitro · PMID 1999398

What is GHK-Cu?

GHK-Cu is a 1:1 copper(II) coordination complex of the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys). The histidine residue coordinates the copper atom, making copper an integral part of the active molecular structure. It is characterized in cultured fibroblasts as a modulator of extracellular-matrix-remodeling signaling through copper-peptide coordination chemistry.In vitro · PMID 32371360In vitro · PMID 33263328

How do TB-500 and GHK-Cu differ in size and composition?

TB-500 is a 43-residue peptide derived from the natural protein thymosin beta-4; it is a much larger peptide sequence without metal coordination requirements. GHK-Cu is a 3-residue copper-coordination complex; copper is essential to its structure and signaling. This size and composition difference underlies their divergent research contexts: TB-500 is studied for actin-monomer sequestration and cytoskeletal dynamics, while GHK-Cu is studied for copper-peptide extracellular-matrix signaling.Review · PMID 27450730In vitro · PMID 32371360

What are the primary molecular targets of TB-500 and GHK-Cu?

TB-500 targets actin monomers and modulates cytoskeletal dynamics through actin-sequestering interactions in cultured cells. GHK-Cu targets extracellular-matrix-remodeling signaling pathways in fibroblasts, measured for modulation of collagen synthesis and matrix-metalloproteinase expression. One peptide focuses on intracellular actin dynamics; the other on extracellular-matrix remodeling signaling.In vitro · PMID 1999398In vitro · PMID 28805225

What is the scope of TB-500 and GHK-Cu research?

Published research on TB-500 focuses on in-vitro characterization of actin binding, structural properties by NMR spectroscopy, actin-sequestering activity, and cultured cell studies of cytoskeletal dynamics and cell mobility. Research on GHK-Cu focuses on computational modeling of copper binding, in-vitro cell-culture experiments measuring extracellular-matrix signaling, and analytical applications in protein crystallography. Both literatures emphasize in-vitro biochemical and cell-culture characterization.Review · PMID 27450730In vitro · PMID 32371360In vitro · PMID 28805225

Cited literature

  1. Actin-Induced Structure in the Beta-Thymosin Family of Intrinsically Disordered Proteins.Intrinsically disordered proteins · 2016PMID 27450730 ↗
  2. Structure, function, and evolution of the beta-thymosin/WH2 (WASP-Homology2) actin-binding module.Current protein & peptide science · 2007PMID 17947587 ↗
  3. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable.Journal of biological chemistry · 1991PMID 1999398 ↗
  4. Structural requirements for thymosin beta4 in its contact with actin. An NMR-analysis of thymosin beta4 mutants in solution and correlation with their biological activity.Journal of biological chemistry · 2000PMID 10848969 ↗
  5. Theoretical study of copper binding to GHK peptide.Journal of inorganic biochemistry · 2020PMID 32371360 ↗
  6. The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography.IUCrJ · 2020PMID 33263328 ↗
  7. Cooperative, ion-sensitive co-assembly of tripeptide hydrogels.Chemical communications (Cambridge, England) · 2017PMID 28805225 ↗

Research-literature characterization, provided for research context only. For laboratory research use only. Not for human consumption.